HealthCor Management, L.P. Buys Intuitive Surgical Inc, Zimmer Biomet Holdings Inc, Baxter International Inc, Sells Humana Inc, Elanco Animal Health Inc, Neurocrine Biosciences Inc

• New Purchases: ISRG, ZBH, BAX, BIIB, LH, JNJ, HOLX, QGEN, GMAB, NVST, RTIX, ZGNX, AUPH,
• Added Positions: WMGI, DHR, VRTX, MRK, CHNG, BPMC, BLUE, SYK, NUVA, IQV, ALC, STML, VRAY, PTE,
• Reduced Positions: HUM, NBIX, BMY, ABT, BSX, GILD, NVRO, HAE, XENT, MDT, HZNP, MYOK, SEM, CNMD, CLVS, HCA, PSNL,
• Sold Out: ELAN, AMRN, ALGN, ANTM, ALNY, BDX, RDUS, CNC, THC, ADPT, IRWD, ACAD,

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

1. Edwards Lifesciences Corp (EW) - 625,990 shares, 5.21% of the total portfolio. Shares added by 0.60%
2. Neurocrine Biosciences Inc (NBIX) - 1,493,480 shares, 5.10% of the total portfolio. Shares reduced by 37.02%
3. Merck & Co Inc (MRK) - 1,558,290 shares, 4.97% of the total portfolio. Shares added by 20.57%
4. Biogen Inc (BIIB) - 550,000 shares, 4.85% of the total portfolio.
5. Intuitive Surgical Inc (ISRG) - 235,205 shares, 4.81% of the total portfolio. New Position

HealthCor Management, L.P. initiated holding in Intuitive Surgical Inc. The purchase prices were between $484.58 and $545.01, with an estimated average price of $519.06. The stock is now traded at around $554.44. The impact to a portfolio due to this purchase was 4.81%. The holding were 235,205 shares as of .

HealthCor Management, L.P. initiated holding in Zimmer Biomet Holdings Inc. The purchase prices were between $116.73 and $142.61, with an estimated average price of $132.91. The stock is now traded at around $145.03. The impact to a portfolio due to this purchase was 3.76%. The holding were 723,370 shares as of .

HealthCor Management, L.P. initiated holding in Baxter International Inc. The purchase prices were between $81.4 and $89.78, with an estimated average price of $85.35. The stock is now traded at around $80.74. The impact to a portfolio due to this purchase was 3.42%. The holding were 1,032,820 shares as of .

HealthCor Management, L.P. initiated holding in Biogen Inc. The purchase prices were between $217.44 and $243.88, with an estimated average price of $232.74. The stock is now traded at around $275.15. The impact to a portfolio due to this purchase was 3.15%. The holding were 356,860 shares as of .

HealthCor Management, L.P. initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $159.77 and $178.1, with an estimated average price of $169.92. The stock is now traded at around $169.40. The impact to a portfolio due to this purchase was 3.01%. The holding were 473,480 shares as of .

HealthCor Management, L.P. initiated holding in Johnson & Johnson. The purchase prices were between $126.95 and $142.14, with an estimated average price of $131.85. The stock is now traded at around $130.96. The impact to a portfolio due to this purchase was 1.68%. The holding were 343,540 shares as of .

HealthCor Management, L.P. added to a holding in Wright Medical Group NV by 1962.36%. The purchase prices were between $20.05 and $29.94, with an estimated average price of $23.8. The stock is now traded at around $29.39. The impact to a portfolio due to this purchase was 1.53%. The holding were 2,062,360 shares as of .

HealthCor Management, L.P. added to a holding in Danaher Corp by 35.27%. The purchase prices were between $135.4 and $146.47, with an estimated average price of $141.32. The stock is now traded at around $136.15. The impact to a portfolio due to this purchase was 0.98%. The holding were 686,980 shares as of .

HealthCor Management, L.P. added to a holding in Vertex Pharmaceuticals Inc by 26.23%. The purchase prices were between $166.23 and $187.09, with an estimated average price of $177.05. The stock is now traded at around $205.00. The impact to a portfolio due to this purchase was 0.91%. The holding were 679,690 shares as of .

HealthCor Management, L.P. added to a holding in Merck & Co Inc by 20.57%. The purchase prices were between $79.73 and $86.91, with an estimated average price of $84.08. The stock is now traded at around $84.55. The impact to a portfolio due to this purchase was 0.85%. The holding were 1,558,290 shares as of .

HealthCor Management, L.P. added to a holding in Change Healthcare Inc by 58.15%. The purchase prices were between $11.5 and $15.2, with an estimated average price of $13.76. The stock is now traded at around $13.90. The impact to a portfolio due to this purchase was 0.72%. The holding were 4,254,430 shares as of .

HealthCor Management, L.P. added to a holding in Blueprint Medicines Corp by 59.32%. The purchase prices were between $72.9 and $101.41, with an estimated average price of $86.48. The stock is now traded at around $72.09. The impact to a portfolio due to this purchase was 0.63%. The holding were 609,417 shares as of .

HealthCor Management, L.P. sold out a holding in Elanco Animal Health Inc. The sale prices were between $25.62 and $34.96, with an estimated average price of $30.01.

HealthCor Management, L.P. sold out a holding in Amarin Corp PLC. The sale prices were between $13.89 and $23.16, with an estimated average price of $17.5.

HealthCor Management, L.P. sold out a holding in Align Technology Inc. The sale prices were between $173.16 and $286.65, with an estimated average price of $208.53.

HealthCor Management, L.P. sold out a holding in Anthem Inc. The sale prices were between $237.69 and $310.48, with an estimated average price of $273.94.

HealthCor Management, L.P. sold out a holding in Alnylam Pharmaceuticals Inc. The sale prices were between $70.9 and $87.82, with an estimated average price of $79.04.

HealthCor Management, L.P. sold out a holding in Becton, Dickinson and Co. The sale prices were between $236.34 and $262.48, with an estimated average price of $253.08.